Ind-Swift Laboratories Limited
NSE: INDSWFTLAB BSE: INDSWFTLAB
NSE
89.70
-0.64 (-0.71%)
Prev Close
90.34
Open Price
89.55
Volume
38,624
Today Low / High
89.55 / 90.56
52 WK Low / High
68.72 / 124
Range
85 - 94
BSE
90.00
0.34 (0.38%)
Prev Close
89.66
Open Price
90.11
Volume
694
Today Low / High
89.67 / 90.44
52 WK Low / High
67.15 / 124.45
Range
86 - 95
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 89.7 (target range: 85 - 94), reflecting a change of -0.64 (-0.70844%). On the BSE, it is listed at 90 (target range: 86 - 95), showing a change of 0.34 (0.37921%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
02 Jan
90.00
1.72%
01 Jan
89.24
1.40%
31 Dec
89.11
-1.08%
30 Dec
89.00
0.53%
29 Dec
91.00
-1.51%
26 Dec
92.00
-0.53%
24 Dec
93.00
-1.18%
23 Dec
93.50
-0.66%
22 Dec
93.20
1.13%
19 Dec
95.45
-2.14%
18 Dec
93.59
0.49%
17 Dec
95.42
-1.92%
16 Dec
97.62
-2.25%
15 Dec
99.50
-1.89%
12 Dec
96.90
1.04%
11 Dec
92.31
3.73%
10 Dec
89.60
4.51%
Ind-Swift Laboratories Limited Graph
Ind-Swift Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ind-Swift Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 89.70, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 90.00 | 90.90 | 81.81 - 99.99 |
| 91.80 | 73.44 - 110.16 | ||
| 92.70 | 64.89 - 120.51 | ||
| Bearish Scenario | 90.00 | 89.10 | 80.19 - 98.01 |
| 88.20 | 70.56 - 105.84 | ||
| 87.30 | 61.11 - 113.49 |
Overview of Ind-Swift Laboratories Limited
ISIN
INE915B01019
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
84,619
Market Cap
6,731,437,864
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
-9.63
DCF
101
Financial Ratios Every Investor Needs
Stock Dividend of INDSWFTLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2011-09-20 | September 20, 11 | 1 | 1 | 2011-09-21 | 2011-10-26 | 2011-05-25 |
| 2010-09-16 | September 16, 10 | 1 | 1 | 2010-09-18 | 2010-10-22 | 2010-05-29 |
| 2009-09-17 | September 17, 09 | 1 | 1 | 2009-09-19 | 2009-10-24 | 2009-06-29 |
| 2008-09-18 | September 18, 08 | 1 | 1 | 2008-09-22 | 2008-11-01 | 2008-06-19 |
| 2007-09-21 | September 21, 07 | 1 | 1 | 2007-09-25 | 2007-11-01 | 2007-07-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 561.71 Cr | 287.95 Cr | 273.76 Cr | 0.4874 | 2.30 Cr | 119.16 Cr | -43.87 Cr | 250.48 Cr | 37.25 | 285.20 Cr | 0.4459 |
| 2024-03-31 | 1,280.90 Cr | 867.58 Cr | 413.32 Cr | 0.3227 | 35.52 Cr | 36.78 Cr | 200.90 Cr | 420.96 Cr | 91.18 | 782.41 Cr | 0.3286 |
| 2023-03-31 | 1,207.31 Cr | 766.86 Cr | 440.45 Cr | 0.3648 | 42.57 Cr | 20.52 Cr | 181.52 Cr | 47.60 Cr | 8.06 | 235.77 Cr | 0.0394 |
| 2022-03-31 | 1,038.73 Cr | 629.12 Cr | 409.61 Cr | 0.3943 | 32.72 Cr | 20.41 Cr | 92.42 Cr | -2.15 Cr | -0.36 | 235.02 Cr | -0.0021 |
| 2021-03-31 | 891.34 Cr | 516.24 Cr | 375.10 Cr | 0.4208 | 33.01 Cr | 15.95 Cr | 110.96 Cr | -3.15 Cr | -0.53 | 198.25 Cr | -0.0035 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 428.04 Cr | 1,438.34 Cr | 265.37 Cr | 1,172.9997 Cr | 40.84 Cr | -387.20 Cr | 114.18 Cr | 260.07 Cr | 0.00 Cr | 0.00 Cr | 252.00 Cr | 220.5801 Cr |
| 2024-03-31 | 493.81 Cr | 1,460.43 Cr | 648.37 Cr | 936.1773 Cr | 16.62 Cr | -415.31 Cr | 108.73 Cr | 5.36 Cr | 5.35 Cr | 0.00 Cr | 110.54 Cr | 216.5571 Cr |
| 2023-03-31 | 18.20 Cr | 1,824.06 Cr | 1,142.13 Cr | 681.9307 Cr | 862.10 Cr | 843.90 Cr | 438.60 Cr | 592.75 Cr | 0.00 Cr | 0.12 Cr | 25.38 Cr | 371.0889 Cr |
| 2022-03-31 | 21.48 Cr | 1,800.79 Cr | 1,199.93 Cr | 600.9723 Cr | 953.02 Cr | 931.54 Cr | 428.50 Cr | 636.84 Cr | 0.00 Cr | 0.15 Cr | 29.06 Cr | 334.4653 Cr |
| 2021-03-31 | 11.60 Cr | 1,818.45 Cr | 1,215.03 Cr | 603.5061 Cr | 1,005.35 Cr | 993.75 Cr | 375.67 Cr | 748.09 Cr | 0.00 Cr | 0.17 Cr | 27.23 Cr | 314.5231 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -25.4735 Cr | -109.6222 Cr | 69.2046 Cr | -89.8796 Cr | -66.4687 Cr | 427.4607 Cr | -64.4061 Cr | 34.5943 Cr | 20.9929 Cr | 0.0000 Cr | -43.1578 Cr |
| 2024-03-31 | -163.1152 Cr | -122.6903 Cr | 698.9138 Cr | -207.6321 Cr | 413.2799 Cr | 431.4797 Cr | -44.5169 Cr | 420.9616 Cr | -37.4278 Cr | 0.0000 Cr | 32.8866 Cr |
| 2023-03-31 | 194.6196 Cr | -13.3683 Cr | -185.6574 Cr | 181.8489 Cr | -4.4061 Cr | 17.0715 Cr | -12.7707 Cr | 113.1690 Cr | -45.9089 Cr | 0.0000 Cr | -10.1029 Cr |
| 2022-03-31 | 150.2741 Cr | 4.7722 Cr | -140.8769 Cr | 131.8592 Cr | 14.1694 Cr | 25.7700 Cr | -18.4149 Cr | 12.5324 Cr | -36.0118 Cr | 0.0000 Cr | -52.8337 Cr |
| 2021-03-31 | 134.9471 Cr | -10.1716 Cr | -123.7469 Cr | 130.5505 Cr | 1.0287 Cr | 11.6110 Cr | -3.9104 Cr | 18.0085 Cr | -39.8529 Cr | 0.0000 Cr | -32.8484 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 152.64 Cr | 77.65 Cr | 74.99 Cr | 0.4913 | -5.50 Cr | 7.99 Cr | 1.00 | 19.34 Cr | 0.0523 |
| 2025-06-30 | 152.73 Cr | 73.09 Cr | 79.65 Cr | 0.5215 | 47.11 Cr | 8.77 Cr | 1.28 | 3.04 Cr | 0.0574 |
| 2025-03-31 | 507.92 Cr | 246.11 Cr | 261.82 Cr | 0.5155 | -7.09 Cr | 249.12 Cr | 42.16 | 283.31 Cr | 0.4905 |
| 2024-12-31 | 8.66 Cr | 6.22 Cr | 2.45 Cr | 0.2822 | -14.78 Cr | 0.01 Cr | 0.00 | -0.72 Cr | 0.0007 |
| 2024-09-30 | 11.96 Cr | 8.31 Cr | 3.64 Cr | 0.3048 | -12.01 Cr | 0.41 Cr | 0.07 | 1.21 Cr | 0.0346 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 399.93 Cr | 33.53 Cr | 433.46 Cr | 175.27 Cr | 108.58 Cr | 843.81 Cr | 271.44 Cr | 1,544.43 Cr | 236.99 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 467.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,172.96 Cr |
| 2025-03-31 | 428.04 Cr | 39.37 Cr | 481.64 Cr | 164.52 Cr | 114.18 Cr | 865.35 Cr | 260.07 Cr | 1,438.34 Cr | 265.37 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 438.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,011.52 Cr |
| 2024-09-30 | 438.46 Cr | 0.00 Cr | 438.46 Cr | 57.55 Cr | 9.33 Cr | 586.80 Cr | 5.02 Cr | 1,188.02 Cr | 176.50 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 8.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 249.12 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,761.70 | ₹4,226,908,416,649.00 | ₹1,472,684.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,649.00 | ₹1,765,100,588,420.00 | ₹672,729.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,933.50 | ₹1,331,275,138,240.00 | ₹159,854.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,256.30 | ₹1,045,885,485,158.00 | ₹474,864.00 |
| Lupin Limited | LUPIN | ₹2,152.80 | ₹983,396,469,557.00 | ₹1,450,118.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹929.75 | ₹935,546,052,203.00 | ₹340,641.00 |
| Mankind Pharma Limited | MANKIND | ₹2,240.30 | ₹924,807,202,802.00 | ₹236,960.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,233.00 | ₹716,128,401,159.00 | ₹1,687,647.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,658.00 | ₹676,498,770,000.00 | ₹74,886.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,115.90 | ₹602,425,959,854.00 | ₹1,054,080.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,074.60 | ₹585,453,798,351.00 | ₹186,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,470.00 | ₹372,945,200,460.00 | ₹585,877.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,846.80 | ₹355,666,734,403.00 | ₹279,657.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,879.00 | ₹294,347,146,324.00 | ₹211,140.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,530.10 | ₹290,064,943,454.00 | ₹281,696.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,467.00 | ₹238,376,011,923.00 | ₹901,810.00 |
| Eris Lifesciences Limited | ERIS | ₹1,552.50 | ₹211,476,723,278.00 | ₹31,549.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,407.00 | ₹210,175,000,000.00 | ₹37,561.00 |
| Cohance Lifesciences Limited | COHANCE | ₹503.45 | ₹192,603,426,633.00 | ₹402,100.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹14,520.00 | ₹186,289,988,280.00 | ₹66,617.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,080.40 | ₹171,241,709,174.00 | ₹154,663.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹925.75 | ₹165,810,962,153.00 | ₹1,143,584.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹826.80 | ₹162,518,390,923.00 | ₹53,139.00 |
| Granules India Limited | GRANULES | ₹613.00 | ₹148,755,922,908.00 | ₹481,822.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,842.80 | ₹140,074,353,389.00 | ₹31,582.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹907.60 | ₹111,345,591,445.00 | ₹34,897.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,795.50 | ₹96,201,718,381.00 | ₹4,150.00 |
| Strides Pharma Science Limited | STAR | ₹987.35 | ₹91,006,729,168.00 | ₹1,033,249.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹443.95 | ₹67,969,658,649.00 | ₹54,474.00 |
| FDC Limited | FDC | ₹412.55 | ₹67,167,300,154.00 | ₹92,294.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹736.30 | ₹66,743,602,572.00 | ₹83,116.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹318.25 | ₹62,243,912,942.00 | ₹104,610.00 |
| Sequent Scientific Limited | SEQUENT | ₹206.80 | ₹51,663,565,769.00 | ₹340,926.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹420.50 | ₹45,819,893,933.00 | ₹29,638.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹136.29 | ₹44,229,047,229.00 | ₹844,523.00 |
| Innova Captab Limited | INNOVACAP | ₹728.50 | ₹41,688,360,777.00 | ₹9,669.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹782.70 | ₹39,697,843,484.00 | ₹40,095.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,332.90 | ₹38,583,868,094.00 | ₹2,487.00 |
| Suven Life Sciences Limited | SUVEN | ₹170.52 | ₹37,583,633,678.00 | ₹748,782.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹403.50 | ₹36,827,445,000.00 | ₹87,942.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹329.40 | ₹33,033,057,476.00 | ₹13,223.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹434.45 | ₹30,587,778,088.00 | ₹4,669.00 |
Key Executives
Vice President of HR
Akashdeep Sharma
Gender: Not Specified
Year Born:
Vice President of Accounts
Lalit Goyal
Gender: Not Specified
Year Born:
Chief Financial Officer
Gagan Aggarwal
Gender: male
Year Born:
Joint MD & Whole Time Director
Himanshu Jain
Gender: male
Year Born: 1982
Chairman & MD
Navrattan Munjal
Gender: male
Year Born: 1952
Vice President of Corporate Affairs, Compliance Officer & Company Secretary
Pardeep Verma
Gender: male
Year Born:
Executive Director
Rishav Mehta
Gender: male
Year Born: 1991
Executive Director
Sahil Munjal
Gender: male
Year Born: 1980
Senior Vice President of Marketing
Varun Chhabra
Gender: Not Specified
Year Born:
Chief Operating Officer
Anil Ratanlal Agrawal
Gender: Not Specified
Year Born:
FAQs about Ind-Swift Laboratories Limited
Who is the CEO of the company?
The CEO is Navrattan R. Munjal.
What is the current market price of the stock?
The current price is ₹91.55.
What is the 52-week price range?
The range is ₹68.72-124.
What is the market capitalization of the company?
The market capitalization is ₹673.14 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 2.75.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ind-Swift Laboratories Limited (ISIN: INE915B01019) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹673.14 crores and an average daily volume of 84,619 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.